Background detail
What Changed Public Hearing Regarding Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products
What Happened Public Hearing Regarding Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products. Official publication from USTR dated Mon, 21 Se. Official link: https://ustr.gov/about/policy-offices/press-office/press-releases/2026/september/public-hearing-regarding-section-301-investigation-germanys-persistent-underpayment-innovative.
Who Is Affected Importers and distributors bringing covered goods into United States, Germany, European Union.
Why It Matters Duty treatment covered by “Public Hearing Regarding Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Pr” may change landed-cost assumptions for United States, Germany, European Union; recalculate only after confirming scope and effective date in the official text.
What To Check Confirm product scope and effective date in the official text before repricing.
Importer Advice Importers of the covered goods can re-check landed cost and the effective date of the new measure — do not assume SKU scope beyond the official notice.
Recommended Actions - Confirm product scope and effective date in the official text before repricing. - Open and archive the official source link
Verified Sources - **USTR** (government, ★★★★★) — [Official link](https://ustr.gov/about/policy-offices/press-office/press-releases/2026/september/public-hearing-regarding-section-301-investigation-germanys-persistent-underpayment-innovative) · retrieved 2026-09-27T11:39:59.704Z · confidence 97
Timeline - 2026-09-27: Discovered by Intelligence Factory - Mon, 21 Se: Official source retrieved
Affected Countries - United States - Germany - European Union
Affected Industries - Cross-border Trade
References - USTR: https://ustr.gov/about/policy-offices/press-office/press-releases/2026/september/public-hearing-regarding-section-301-investigation-germanys-persistent-underpayment-innovative
Last Updated 2026-09-27
Confidence 97%